NCT03954314 - DEPOSITION - Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery | Biotech Hunter

Enrollment

3,242

Participants

Timeline

Start Date

September 17, 2019

Primary Completion Date

November 28, 2023

Study Completion Date

November 28, 2023

Conditions

BleedingSurgical Blood LossSeizures

Interventions

DRUG

Tranexamic Acid

Tranexamic Acid is a medication used to treat or prevent excessive blood loss from major trauma, post partum, surgery, tooth removal, nose bleeds, and heavy menstruation.

Trial Locations (16)

Unknown

Kelowna General Hospital, Kelowna

CHUM, Montreal

CIUSSS NIM/Hôpital Sacré-Coeur de Montréal, Montreal

IUCPQ, Québec

Beijing Anzhen Hospital, Beijing

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

Nemocnice Agel Třinec, Třinec

University of Malaya, Kuala Lumpur

Auckland City Hospital, Auckland

Petrovsky National Research Centre, Moscow

E.Meshalkin National Medical Research Center, Novosibirsk

Saint-Petersburg State University Hospital, Saint Petersburg

R2H 2A6

St. Boniface Hospital, Winnipeg

E2L 4L2

Saint John Regional Hospital, Saint John

L8L 2X2

Hamilton Health Sciences - General Hospital, Hamilton

H1T 1C8

Montreal Heart Institute, Montreal